tradingkey.logo

BUZZ-Danaher rises after forecasting Q4 revenue growth

ReutersJan 14, 2025 11:23 AM

** Shares of Danaher DHR.N rise 1.7% to $243.86 premarket

** Life sciences co said on Monday it expects Q4 revenue to increase in low-single digit percent range year-over-year

** Preliminary results indicate continued but expected recovery in co's bioprocessing unit, brokerage Leerink Partners says

** "We continue to see DHR as a sector leader and an M&A compounder/operator with a market-leading franchise in bioprocessing," Leerink says

** DHR fell 0.8% in 2024

(Reporting by Puyaan Singh)

((Puyaan.Singh@thomsonreuters.com;))

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI